Enhanced immunogenicity of a contraceptive vaccine using diverse synthetic carriers with permissible adjuvant

Vaccine

Volumn 19, Issue 25-26, 2001, Pages 3384-3389

  Gupta, Anushree ^a   Pal, Rahul ^a   Ahlawat, Sarita ^a   Bhatia, Prakash ^a   Singh, Om ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Human chorionic gonadotropin; Immunocontraception; Th peptide

Indexed keywords

ALUMINUM POTASSIUM SULFATE; CHORIONIC GONADOTROPIN VACCINE; CONTRACEPTIVE VACCINE; IMMUNOLOGICAL ADJUVANT; NEUTRALIZING ANTIBODY; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ARTICLE; CONJUGATION; FEMALE; HAPLOTYPE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; CHORIONIC GONADOTROPIN; FEMALE; H-2 ANTIGENS; HAPLOTYPES; HUMANS; KINETICS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDES; PREGNANCY; SPECIES SPECIFICITY; T-LYMPHOCYTES, HELPER-INDUCER; TETANUS TOXOID; VACCINES, CONJUGATE; VACCINES, CONTRACEPTIVE;

EID: 0035858102     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00079-2     Document Type: Article

References (31)

1. Isoimmunization against human chorionic gonadotropin with conjugates of processed β-subunit of the hormone and tetanus toxoid
2. Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines inducing antibodies against human chorionic gonadotropin
3. Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine
4. Bioneutralization capacity of the antibodies generated in women by the beta subunit of human chorionic gonadotropin (βhCG) and βhCG associated with alpha subunit of ovine luteinizing hormone linked to carriers
5. A vaccine that prevents pregnancy in women
6. Carrier-priming leads to hapten-specific suppression
7. Epitope-specific regulation: I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses
8. Epitopic suppression in synthetic vaccine models: Analysis of effector mechanisms
9. Carrier-induced epitopic suppression is initiated through clonal dominance
10. Effect of priming with carrier on response to conjugate vaccine
11. Use of prior vaccinations for the development of new vaccines
12. Carrier-induced, hapten-specific suppression: A problem of antigen presentation?
13. Immunological focusing by the mouse major histocompatibility complex: Mouse strains confronted with distantly related lysozymes confine their attention to very few epitopes
14. Identification of distinct predominant epitopes recognized by myoglobin-specific T cells under the control of different Ir genes and characterization of representative T cell clones
15. Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins
16. On the interaction of promiscuous antigenic peptides with different DR alleles: Identification of common structural motifs
17. Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: Correlation with a cytotoxic T cell epitope
18. Protein thiolation and reversible protein-protein conjugation. N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent
19. Bypass by an alternate 'carrier' of acquired unresponsiveness to hCG upon repeated immunization with tetanus conjugated vaccines
20. Protein and cell membrane iodination with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3α-6α-diphenylglycouril
21. Ligand: A versatile computerized approach for characterization of ligand binding systems
22. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules
23. A 16-amino acid peptide of respiratory syncytial virus 1A protein contains two overlapping T cell-stimulating sites distinguishable by class II MHC restriction elements
24. Construction of synthetic immunogen: Use of new T-helper epitope on malaria circumsporozoite protein
25. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants
26. A synthetic vaccine constructed by copolymerization of B and T cell determinants
27. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope
28. 'Universal' T helper cell determinants enhance the immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide
29. Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid
30. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines
31. Mechanisms influencing the immunodominance of T cell determinants